Jakob Ribbing
- Statistics and Probability top 2%
- Statistical Methods in Clinical Trials 5
- Statistical Methods and Bayesian Inference 3
- Transplantation top 10%
- Pharmacology top 5%
- Pharmacology top 5%
- Anesthesiology and Pain Medicine top 10%
-
- Asthma and respiratory diseases 7
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 6
- Inhalation and Respiratory Drug Delivery 5
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Respiratory and Cough-Related Research 2
-
- Inflammatory Bowel Disease 2
- Co-authors
- E. Niclas JonssonLars LindbomJoakim NybergOla CasterSteven W. MartinMats O. KarlssonWalter ReinischBengt Hamrén
- Journals
- European Respiratory Journal (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Clinical Pharmacokinetics (1 paper)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Jakob Ribbing
20 papers receiving 986 citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Statistics and Probability 149
- Transplantation 36
- Pharmacology 95
- Pharmacology 174
- Anesthesiology and Pain Medicine 43
Countries citing papers authored by Jakob Ribbing
This map shows the geographic impact of Jakob Ribbing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakob Ribbing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakob Ribbing more than expected).
Fields of papers citing papers by Jakob Ribbing
This network shows the impact of papers produced by Jakob Ribbing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakob Ribbing. The network helps show where Jakob Ribbing may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jakob Ribbing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 22 | |
| 3 | 2022 | 5 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 7 | |
| 6 | 2021 | 3 | |
| 7 | 2016 | 11 | |
| 8 | Predicting Reductions in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations from FEV1-A Model-Based Meta-Analysis of Literature Data from Controlled Randomized Clinical Trials | 2015 | 2 |
| 9 | 2015 | 9 | |
| 10 | 2013 | 4 | |
| 11 | 2013 | 9 | |
| 12 | 2013 | 5 | |
| 13 | 2012 | 14 | |
| 14 | 2012 | 10 | |
| 15 | 2010 | 32 | |
| 16 | 2007 | 1 | |
| 17 | 2007 | 61 | |
| 18 | Covariate Model Building in Nonlinear Mixed Effects Models | 2007 | 5 |
| 19 | 2004 | 137 | |
| 20 | Perl-speaks-NONMEM (PsN)—a Perl module for NONMEM related programmingbreakdown → | 2004 | 635 |
About Jakob Ribbing
Jakob Ribbing is a scholar working on Statistics and Probability, Pulmonary and Respiratory Medicine and Physiology, having authored 21 papers that have together received 1.0k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Inhalation and Respiratory Drug Delivery (5 papers), Statistical Methods in Clinical Trials (5 papers), Statistical Methods and Bayesian Inference (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Respiratory and Cough-Related Research (2 papers) and Inflammatory Bowel Disease (2 papers). The work is most often cited by research in Statistics and Probability (149 citations), Transplantation (36 citations) and Pharmacology (95 citations). Jakob Ribbing has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include E. Niclas Jonsson, Lars Lindbom, Joakim Nyberg, Ola Caster, Steven W. Martin, Mats O. Karlsson, Walter Reinisch, Bengt Hamrén, Maria Svensson and Fabio Cataldi. Their work appears in journals such as European Respiratory Journal, Clinical Pharmacology & Therapeutics and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.